hotspot -WSS

hotspot

author：leisure time 2025-10-01 01:50:47 - browse：5645

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Pharma companies must ensure equitable access to obesity drugs

explore

hotspot

WSS

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Medical experts are missing from AI regulatory conversations

Cigna wins case to block Amy Bricker's move to CVS

The kidney, in all its complexity, is captured in a new atlas

DOJ, FTC to increase scrutiny of all types of health care mergers

hotspot

hotspot

focus

How one medical school became remarkably diverse

Seattle police shoot person suspected in downtown stabbing

Affirmative action in medical school literally saved lives

Norman Reedus' Daryl Dixon

Supreme Court strikes down use of affirmative action

NIH tests clinical research in primary care with $30 million program

Affirmative action in medical school literally saved lives

Trump got a 'target letter.' What is one and what does it mean?

Cancer drug shortages should be causing more outrage

India sets sights on home

knowledge

Cheap, fast test for Zika and dengue could cost just $1

Seattle police shoot person suspected in downtown stabbing

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

'Essentially witchcraft:' A former naturopath takes on the field

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

New warning issued for rebooking air travel after delays, cancellations

explore

hotspot

focus

knowledge